Treatment of Vertebral Artery Dissection

Diagnosis

The American Heart Association recommends CT angiography (CTA), MR angiography (MRA), or catheter-based contrast angiography as the preferred diagnostic modalities for vertebral artery dissection (Class I recommendation) 1
Carotid duplex ultrasonography may identify a dissection flap and differential flow in the true and false lumens, but may miss dissections that begin above the angle of the mandible 2, 3
Selective catheterization of vertebral arteries may be necessary to delineate collateral filling via the circle of Willis, which guides management 2, 3

Medical Management

Antithrombotic Therapy

The American Stroke Association recommends antithrombotic therapy for 3-6 months for symptomatic vertebral artery dissection (Class IIa recommendation) 3, 4
Initial treatment options include anticoagulation with intravenous heparin followed by warfarin (target INR 2.0-3.0) 3, 4
Antiplatelet therapy with aspirin (81-325 mg daily) or clopidogrel (75 mg daily) may be used as an alternative to anticoagulation 4
After the initial 3-6 month period, transition to antiplatelet therapy is recommended 3

Blood Pressure Management

The American Heart Association states that the safety and effectiveness of pharmacological therapy with beta-adrenergic antagonists, angiotensin inhibitors, or non-dihydropyridine calcium channel antagonists to lower blood pressure and reduce arterial wall stress are not well established (Class IIb recommendation) 3, 4

Invasive Treatment

Surgical or endovascular revascularization is reserved for patients with persistent or recurrent symptoms that fail to respond to antithrombotic therapy 2, 3
Endovascular options include angioplasty and stenting, which may be considered when ischemic neurological symptoms have not responded to antithrombotic therapy (Class IIb recommendation) 4
Surgical options include direct vertebral artery repair or resection with vein graft replacement 2

Prognosis and Follow-up

With appropriate antithrombotic treatment, the prognosis is usually favorable 2, 3
The annual rate of recurrent stroke, TIA, or death was reported as 8.3% in patients treated with anticoagulants versus 12.4% in those treated with aspirin in one observational study 3, 5

Special Considerations

Anticoagulation may adversely influence the outcome if subarachnoid hemorrhage occurs due to intracranial extension of the dissection 2
A high index of suspicion for vertebral artery dissection should be maintained in younger patients with stroke symptoms, as it accounts for 10-15% of ischemic strokes in patients under 45 years 1

Treatment of Vertebral Artery Dissection

Initial Antithrombotic Management

The risk of hemorrhagic transformation appears low (<5%) in patients with vertebral artery dissection 6
Anatomic healing occurs in 72-100% of patients with medical management alone 6

Critical Caveat: Intracranial Extension

Anticoagulation is contraindicated if subarachnoid hemorrhage occurs from intracranial extension of the dissection, as intracranial vertebrobasilar dissections carry higher rupture risk 6

Prognosis

Dissections that do not fully heal anatomically are not associated with increased recurrent stroke risk, so further intervention for asymptomatic lesions is not warranted 6

Treatment of Vertebral Artery Dissection

Initial Management

The American Heart Association/American Stroke Association recommends initiating antithrombotic therapy immediately for at least 3-6 months using either antiplatelet agents or anticoagulation for patients with vertebral artery dissection causing ischemic stroke or TIA, as both approaches show equivalent efficacy in preventing recurrent events 7
The choice between antiplatelet and anticoagulation approaches is reasonable and should be based on bleeding risk and patient-specific factors, as the CADISS trial showed no statistically significant difference (OR 0.56, 95% CI 0.10-3.21) 7
Antiplatelet therapy with aspirin 81-325 mg daily or clopidogrel 75 mg daily results in a stroke/death rate of 2% at 3 months and 3.2% at 1 year 7
Anticoagulation with intravenous heparin followed by warfarin (target INR 2.0-3.0) results in a stroke/death rate of 1% at 3 months and 1.6% at 1 year 7

Intervention

Endovascular options, such as angioplasty and stenting, are reserved for patients with persistent or recurrent ischemic symptoms despite optimal antithrombotic therapy, and carry significant risks, including 5.5% periprocedural neurological complications and 26% restenosis rate at 12 months 7, 8

Prognosis and Follow-Up

Most dissections heal spontaneously with appropriate antithrombotic treatment, though a subset will develop complications such as pseudoaneurysm formation 7

Treatment of CVA Secondary to Vertebral Artery Dissection

Medical Management Algorithm

The American College of Cardiology recommends starting IV heparin immediately, then transitioning to warfarin (target INR 2.0-3.0) for extracranial dissection with thrombus, yielding a 1% stroke/death rate at 3 months and 1.6% at 1 year, with an annual recurrent stroke/TIA/death rate of 8.3% with anticoagulation versus 12.4% with aspirin alone 9, 10
Aspirin plus extended-release dipyridamole (200 mg twice daily) reduced vertebrobasilar territory stroke/TIA from 10.8% to 5.7% compared to placebo, and ticlopidine 250 mg twice daily was superior to aspirin alone for secondary prevention in posterior circulation disease 9, 10

Endovascular/Surgical Intervention

For distal vertebrobasilar disease, neurological complications develop in 24%, approaching 80% in urgent revascularization cases, with endovascular treatment carrying 0.3% death risk, 5.5% periprocedural neurological complication risk, and 0.7% posterior stroke risk at 14.2 months, and restenosis occurring in 26% of cases at 12-month follow-up 9, 10

Imaging, Risk‑Factor Management, and Follow‑Up in Vertebral Artery Dissection

Diagnostic Imaging When Non‑Invasive Studies Are Inconclusive

In patients where CTA or MRA does not clearly define the location or severity of a vertebral artery dissection, catheter‑based angiography should be performed to delineate collateral flow via the circle of Willis. [11][12]

Risk‑Factor Modification Aligned with Extracranial Carotid Atherosclerosis Guidelines

Adults with vertebral artery dissection should receive high‑intensity statin therapy, maintain systolic blood pressure < 140 mm Hg, and engage in at least moderate‑intensity physical activity, following the same standards applied to extracranial carotid atherosclerosis. [11][12]

Follow‑Up Imaging Strategy

Serial non‑invasive imaging (CTA or MRA) is reasonable for monitoring disease progression and detecting new lesions in patients after the acute phase of vertebral artery dissection. [11][12]

Antiplatelet Therapy as First‑Line Treatment for Vertebral Artery Dissection

Efficacy and Safety

Antiplatelet therapy is equally effective as anticoagulation for preventing recurrent stroke in vertebral artery dissection and carries a lower risk of major bleeding, making it a reasonable first‑line option for most patients. [13][14]

Therapeutic Regimens

Aspirin (81–325 mg daily) can be used as monotherapy for acute vertebral artery dissection. 13
Clopidogrel (75 mg daily) is an alternative antiplatelet agent for the same indication. 13

Treatment Duration

Antithrombotic therapy should be continued for a minimum of 3–6 months after diagnosis, after which patients may be transitioned to long‑term single antiplatelet therapy. [13][14]

Imaging and Diagnosis

The location of the dissection (extracranial vs. intracranial) must be confirmed with CTA, MRA, or catheter angiography before initiating therapy. [13][14]
Diagnosis should be established using CTA or MRA to delineate the arterial segment involved. 14

Management Algorithms – Extracranial Dissection

For extracranial vertebral artery dissection, start aspirin or clopidogrel immediately after imaging confirmation. 13
Maintain the chosen antiplatelet regimen for 3–6 months before switching to a single long‑term antiplatelet agent. [13][14]

Management Algorithms – Intracranial Dissection

In intracranial vertebral artery dissection, antiplatelet therapy is preferred over anticoagulation because of a higher bleeding risk associated with anticoagulants. 14

Indications for Anticoagulation (Selective Use)

Anticoagulation may be reserved for patients who:

Contraindications in Intracranial Dissection

Anticoagulation should be avoided in intracranial dissections when there is a risk of subarachnoid hemorrhage or confirmed intracranial extension. Careful imaging assessment is required before considering anticoagulants. 14